KBC Group’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34K Hold
1,402
﹤0.01% 1774
2025
Q4
$35K Hold
1,402
﹤0.01% 1705
2025
Q3
$40K Hold
1,402
﹤0.01% 1696
2025
Q2
$35K Sell
1,402
-1,128
-45% -$31.8K ﹤0.01% 1689
2025
Q1
$78K Hold
2,530
﹤0.01% 1613
2024
Q4
$80K Buy
2,530
+1,316
+108% +$62.5K ﹤0.01% 1684
2024
Q3
$70K Hold
1,214
﹤0.01% 1526
2024
Q2
$49K Sell
1,214
-51
-4% -$2.02K ﹤0.01% 1641
2024
Q1
$53K Hold
1,265
﹤0.01% 1529
2023
Q4
$48K Sell
1,265
-217
-15% -$7.23K ﹤0.01% 1564
2023
Q3
$46K Sell
1,482
-1,517
-51% -$52.3K ﹤0.01% 1516
2023
Q2
$95K Sell
2,999
-400
-12% -$13.7K ﹤0.01% 1202
2023
Q1
$124K Hold
3,399
﹤0.01% 1138
2022
Q4
$101K Hold
3,399
﹤0.01% 1195
2022
Q3
$133K Hold
3,399
﹤0.01% 1084
2022
Q2
$131K Buy
+3,399
New +$129K ﹤0.01% 1122

Other funds holding ASTH

KBC Group's ASTH Position: Q1 2026 in Review

KBC Group held its Astrana Health (ASTH) position steady in Q1 2026 at 1,402 shares worth $34K. The position accounts for ﹤0.01% of the portfolio, ranked #1774.

KBC Group first reported a position in ASTH in Q2 2022 and has held it in 16 quarters since. The position peaked at $133K in Q3 2022. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

  • KBC Group held 1,402 shares of Astrana Health worth $34K as of Q1 2026.
  • KBC Group left its Astrana Health share count unchanged in Q1 2026.
  • Astrana Health made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #1774 holding.
  • KBC Group first reported a position in Astrana Health in Q2 2022 and has held it in 16 quarters since.
  • KBC Group's Astrana Health position peaked at $133K in Q3 2022.
  • 171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.